Fresenius SE & Co. KGaA (FSNUY)
Supplies medicines, medical devices, and operates hospitals for chronically ill patients worldwide
$12.71+0.00%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+6.1%
The outlook
FSNUY trades near its 52-week low, with analyst consensus showing "Strong Buy" ratings and an average price target about 24% above the current level. The stock is mixed relative to its moving averages, reflecting uncertain near-term momentum despite the bullish analyst outlook. The trailing P/E of 16.7 sits at a modest valuation.
What’s behind the score
Analyst consensusStrong Buy — 1.3 avg of 3 analysts
Price trendMixed vs its moving averages
52-week range10% of the way from its 52-week low to high
Price targetAvg target +24% vs current price
Analyst price target
~12-month · 3 analysts$15.81average target+24.4% vs now
Now $12.71
Low $14.13High $17.10
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$28.63B
52-wk high
$33.93
52-wk low
$10.33
50-day avg
$11.53
200-day avg
$13.41
Trailing P/E
16.7